INmune Bio Inc. (INMB)
NASDAQ: INMB
· Real-Time Price · USD
2.53
0.08 (3.27%)
At close: Aug 15, 2025, 3:59 PM
2.47
-2.37%
After-hours: Aug 15, 2025, 07:51 PM EDT
INmune Bio Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 33.37M | 19.34M | 20.92M | 33.55M | 31.07M | 26M | 35.85M | 41.81M | 47.83M | 51M | 52.15M | 57.41M | 61.21M | 66.73M | 74.81M | 84.47M | 39.52M | 45.34M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.28M | 49K | 79K | 82K | 81K | 106K | 131K | 129K | 130K | 99K | 99K | 99K | 99K | 99K | 99K | 99K | n/a | n/a |
Receivables | 2.15M | 1.42M | 1.41M | 1.42M | 3.41M | 2.69M | 2.44M | 2.26M | n/a | 2.21M | 8.46M | 4.53M | 5.06M | 5.65M | 5.5M | 5.15M | 3.12M | 2.34M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | 35K | 34K | n/a | n/a | n/a | -5.5M | n/a | n/a | n/a |
Other Current Assets | 505K | 207K | 331K | 864K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 36.03M | 20.96M | 22.66M | 35.85M | 35.49M | 29.82M | 39.94M | 45.61M | 52.61M | 56.88M | 64.67M | 66.66M | 70.55M | 77.06M | 82.61M | 90.93M | 44.05M | 49.21M |
Property-Plant & Equipment | 374K | 278K | 307K | 335K | 363K | 389K | 414K | 444K | 468K | 485K | 507K | 529K | 650K | 681K | 726K | 128K | 137K | 147K |
Goodwill & Intangibles | n/a | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M |
Total Long-Term Assets | 1.65M | 16.84M | 16.9M | 16.93M | 16.96M | 17.01M | 17.06M | 17.09M | 17.11M | 17.1M | 17.12M | 17.14M | 17.26M | 17.29M | 17.34M | 16.74M | 16.65M | 16.66M |
Total Assets | 37.68M | 37.8M | 39.56M | 52.78M | 52.45M | 46.83M | 57M | 62.7M | 69.72M | 73.98M | 81.8M | 83.8M | 87.81M | 94.35M | 99.94M | 107.67M | 60.7M | 65.87M |
Account Payables | 7.86M | 7.3M | 6.56M | 10.64M | 9.42M | 9.29M | 7.9M | 3.67M | 2.38M | 2.08M | 5.21M | 3.46M | 1.69M | 2.55M | 3.81M | 4.22M | 2.36M | 1.57M |
Deferred Revenue | 511K | 480K | n/a | n/a | 521K | 520K | 489K | 496K | 560K | 591K | 616K | 778K | 476K | 584K | -3.67M | 541K | 583K | 591K |
Short-Term Debt | 220K | 146K | 140K | 2.49M | 4.98M | 7.46M | 9.92M | 10M | 10.1M | 7.61M | 5.09M | 2.64M | 113K | 82K | 72K | 38K | 36K | 23K |
Other Current Liabilities | -220K | -146K | 377K | 549K | n/a | n/a | 35K | n/a | 468K | 485K | 520K | 642K | 372K | 511K | 402K | 513K | 556K | 578K |
Total Current Liabilities | 8.59M | 7.93M | 7.22M | 13.82M | 15.05M | 17.45M | 18.46M | 14.36M | 13.05M | 10.28M | 10.92M | 6.89M | 2.29M | 3.23M | 4.36M | 4.81M | 2.99M | 2.2M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.38M | 4.82M | 7.26M | 9.7M | 12.13M | 14.57M | 14.51M | 14.46M | 14.4M | 14.35M | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 804K | 726K | 638K | 550K | 463K | 375K | 287K | 199K | 111K | 24K | n/a |
Total Long-Term Liabilities | 231K | 201K | 244K | 284K | 322K | 360K | 397K | 3.61M | 6.01M | 8.4M | 10.77M | 13.2M | 15.59M | 15.48M | 15.36M | 14.61M | 14.48M | 116K |
Total Liabilities | 8.82M | 8.13M | 7.46M | 14.11M | 15.37M | 17.81M | 18.86M | 17.97M | 19.07M | 18.68M | 21.69M | 20.09M | 17.88M | 18.71M | 19.72M | 19.42M | 17.47M | 2.31M |
Total Debt | 451K | 347K | 384K | 2.91M | 5.43M | 7.94M | 10.44M | 12.91M | 15.39M | 15.37M | 15.31M | 15.38M | 15.33M | 15.28M | 15.23M | 14.53M | 14.49M | 139K |
Common Stock | 27K | 23K | 22K | 22K | 819K | 817K | 817K | 817K | 18K | 18K | 18K | 18K | 18K | 18K | 18K | 18K | 15K | 15K |
Retained Earnings | -197.3M | -172.84M | -163.1M | -153.89M | -141.79M | -132.05M | -121.02M | -112.61M | -104.05M | -97.55M | -91.01M | -85.18M | -77.46M | -70.62M | -63.72M | -54.04M | -44.59M | -37.93M |
Comprehensive Income | -763K | -610K | -575K | -1.04M | -713K | -669K | -799K | -735K | -712K | -708K | -699K | -1.14M | -701K | 56K | 1K | -118K | -50K | 12K |
Shareholders Equity | 28.87M | 29.67M | 32.1M | 38.67M | 37.08M | 29.02M | 38.14M | 44.73M | 50.65M | 55.3M | 60.1M | 63.71M | 69.93M | 75.64M | 80.22M | 88.25M | 43.23M | 63.56M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |